Bekki Yuki, Myers Bryan, Tomiyama Koji, Melcher Marc L, Sasaki Kazunari
The Icahn School of Medicine at Mount Sinai, Recanati-Miller Transplantation Institute, New York City, New York, USA.
Division of Transplantation and Hepatobiliary Surgery, Department of Surgery, University of Rochester Medical Center, Rochester, New York, USA.
Clin Transplant. 2023 Apr;37(4):e14932. doi: 10.1111/ctr.14932. Epub 2023 Feb 17.
The allocation system for livers used the acuity circles (AC) beginning in 2020. In this study, we sought to evaluate the effect of the AC policy on center transplant volumes, from geographic and center practice perspectives.
Using the US national registry data between 2018 and 2022, adult liver transplantations (LTs) were separated into two eras: before AC and after AC.
The number of LT for Model for End-Stage Liver Disease (MELD) scores ≥29 have significantly increased by 10%, and waitlist times for those patients have been significantly shorter after AC. These benefits were not found in patients with MELD scores <29. The geographic distribution of transplant centers reveals that the majority of centers which increased their transplant volume (18 out of 25 centers) are located in high-population states while there are seven transplant centers in nonhigh-population states. The centers in the nonhigh-population states utilized more marginal donation after brain death (DBD) and donation after circulatory death (DCD) donors by 27% and 155%, respectively. MELD scores were significantly lower in the nonhigh-population states compared with those in the high-population states (p < .01).
AC improved the LT access for patients with MELD scores ≥29, which benefited the high-population states. However, aggressive center practices to utilize marginal DBD and DCD donors were able to increase transplant volume and lower median allocation MELD scores.
肝脏分配系统从2020年开始采用 acuity circles(AC)。在本研究中,我们试图从地理和中心实践角度评估AC政策对中心移植量的影响。
利用2018年至2022年美国国家登记数据,将成人肝移植(LT)分为两个时期:AC之前和AC之后。
终末期肝病模型(MELD)评分≥29的肝移植数量显著增加了10%,AC实施后这些患者的等待名单时间显著缩短。MELD评分<29的患者未发现这些益处。移植中心的地理分布显示,移植量增加的大多数中心(25个中心中的18个)位于人口众多的州,而非人口众多的州有7个移植中心。非人口众多州的中心使用边缘性脑死亡后捐赠(DBD)和循环死亡后捐赠(DCD)供体的比例分别增加了27%和155%。与人口众多的州相比,非人口众多的州的MELD评分显著更低(p<0.01)。
AC改善了MELD评分≥29患者的肝移植机会,这有利于人口众多的州。然而,积极利用边缘性DBD和DCD供体的中心实践能够增加移植量并降低分配的MELD评分中位数。